R03AL03 · Respiratory system
Laventair Ellipta (previously Laventair)
Indications
Laventair Ellipta is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Composition
- Active substance
- umeclidinium bromide, vilanterol
- International name (INN)
- umeclidinium bromide;vilanterol
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Laventair Ellipta (previously Laventair)
- Active substance
- umeclidinium bromide, vilanterol
- ATC code
- R03AL03
- Group
- Respiratory system
- Therapeutic area
- Pulmonary Disease, Chronic Obstructive
- Marketing authorisation holder